Status:
COMPLETED
Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Stem Cell Transplant Complications
Eligibility:
All Genders
18+ years
Brief Summary
The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patie...
Detailed Description
The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patie...
Eligibility Criteria
Inclusion
- Patients with multiple myeloma
- Patients who will undergo pre-transplant evaluation with intentions to proceed to autologous stem cell transplant after stem cell collection.
- Patients willing and able to understand and sign an informed consent form
- Patients 18 yrs of age or older
Exclusion
- Patients with unstable psychiatric illness within the past 3 months of study enrollment.
- Patients who are considered unable to perform study evaluations at the investigator's discretion.
- Patients who are unable to read. (If patients require reading glasses, they must be worn at time of test.)
- Patients who do not proceed to stem cell transplant within 60 days of stem cell collection will be excluded from study.
- Patients who receive more than one cycle of chemotherapy between the time of stem cell collection and transplant will be excluded from study.
Key Trial Info
Start Date :
October 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 27 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03355235
Start Date
October 20 2017
End Date
August 27 2019
Last Update
August 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157